A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery

Cancer Research

Volumn 64, Issue 21, 2004, Pages 8002-8008

  Lee, Tong Young ^a   Wu, Han Chung ^a,b   Tseng, Yun Long ^a   Lin, Chin Tarng ^a,c  

^a Graduate Institute of Clinical Medicine   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLEUCYLLEUCYLASPARTYLTHREONYLASPARAGINYLARGINYLPROLYLLEUCYLLEUCYL PROLYLTYROSINE; CHOLESTEROL; DISTEAROYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; DRUG CARRIER; LIPOSOME; PEPTIDE LIBRARY; POLYETHYLENE GLYCOL DISTEAROYLPHOSPHATIDYLCHOLINE; PYRANINE; PYRENE DERIVATIVE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MUCOSA CELL; NASOPHARYNX CARCINOMA; NONHUMAN; NOSE MUCOSA; PHAGE DISPLAY; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; BINDING SITES; DOXORUBICIN; ENDOCYTOSIS; LIPOSOMES; MICE; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; PEPTIDE LIBRARY; PEPTIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 7444237710     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1948     Document Type: Article

References (38)

1. Waterhouse L, Muir C, Shanmugaratnam K, et al. Cancer incidence in five continents, IARC Scientific Publ. No. 42, Vol. IV. Lyon: International Agency for Research on Cancer; 1982.
2. Armstrong RW, Armstrong MJ, Yu CM. Salted fish and inhalants as risk factor for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983;43:2967-70.
3. Ho CK, Lo WCH, Huang PH, et al. Suspected nasopharyngeal carcinoma in three workers with long-term exposure to sulfuric acid vapor. Occup Environ Med 1999;56:426-8.
4. Klein G, Giovanella BC, Lindahl T, et al. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974;71:4737-41.
5. Speth PAJ, Hoesel QGCM, Haanen C. Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet 1988;15:15-31.
6. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999;51:691-743.
7. Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Drugs 1997;54(Suppl 4):15-21.
8. Martin FJ. Clinical pharmacology and antitumor efficacy of DOXIL (pegylated liposomal doxorubicin). In: Lasic DD, Papahadjopoulos D, editors. Medical applications of liposomes. New York: Elsevier Science BV; 1998. p. 635-88.
9. Papahadjopoulos D, Allen TM, Gabizon A, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991;88:11460-4.
10. Dvorak HF, Nagy JA, Dvorak AM. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 1991;3:77-85.
11. Shockley TR, Lin K, Nagy JA, et al. Penetration of tumor tissue by antibodies and other immunoproteins. Ann NY Acad Sci 1991;618:367-82.
12. Li B, Tom JY, Oare D, et al. Minimization of a polypeptide hormone. Science (Wash. DC) 1995;270:1657-60.
13. Wrighton NC, Farrell FX, Chang R, et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science (Wash. DC) 1996;273:458-63.
14. Young AC, Valadon P, Casadevall A, Scharff MD, Sacchettini JC. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J Mol Biol 1997;274:622-34.
15. Wu HC, Jung MY, Chiu CY, et al. Identification of serotype-specific B-cell epitope of dengue virus type 2 and detection of dengue immunized serum samples by epitope-based peptide antigen. J Gen Virol 2003;84:2271-9.
16. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 1996;2:299-305.
17. Spear MA, Breakefield XO, Beltzer J, et al. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells. Cancer Gene Ther 2001;8:506-11.
18. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature (Lond.) 1996;380:364-6.
19. v Integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997;15:542-6.
20. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (Wash. DC) 1998;279:377-80.
21. Hoffman JA, Giraudo E, Singh M, et al. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cells 2003;4:383-91.
22. Joyce JA, Laakkonen P, Bernasconi M, et al. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cells 2003;4:393-403.
23. Lin CT, Wong CI, Chan WY, et al. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Investig 1990;62:713-24.
24. Lin CT, Chan WY, Chen W, et al. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Investig 1993;68:716-27.
25. Tseng YL, Hong RL, Tao MH, Chang FH. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model. Int J Cancer 1999;80:723-30.
26. Habeeb AFSA. Determination of free amino groups in protein by trinitrobenzene sulfuric acid. Anal Biochem 1966;14:328.
27. Zalipsky S, Mullah N, Harding JA, et al. Poly (ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Bioconj Chem 1997;8:111-8.
28. Kirpotin D, Park JW, Hong K, et al. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer in vitro. Biochemistry 1997;36:66-75.
29. Essler M, Ruoslahti E. Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA 2002;99:2252-7.
30. McDonald D. Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002;62:5381-5.
31. Morikawa S, Baluk P, Kaidoh T, et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160:985-1000.
32. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80.
33. Vingerhoeds MH, Steerenberg PA, Hendriks JJGW, et al. Immunoliposome-mediated targeting of doxorubicin of human ovarian carcinoma in vitro and in vivo. Br J Cancer 1996;74:1023-9.
34. Park JW, Hong K, Carter P, et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc Natl Acad Sci USA 1995;92:1327-31.
35. Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta 1993;1151:201-15.
36. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res 1986;46:6387-92.
37. Huang SK, Mayhew E, Gilani S, et al. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res 1992;52:6774-81.
38. Jain RK. Delivery of molecular medicine to solid tumors. Science (Wash. DC) 1996;271:1079-80.